Page 3 of 3
ChemComm
DOI: 10.1039/C3CC44717K
support and AstraZeneca Research centre (France) for assistance.
Table 1. Scope of the Mitsunobu-Tsunoda alkylation for the
enantioselective synthesis of -AAs.
Notes and references
a School of Chemical Sciences and The Maurice Wilkins Centre for
Molecular Biodiscovery, The University of Auckland, 23 Symonds St,
b Oncology iMed, AstraZeneca Pharma, ZI la Pompelle BP 1050, 51689
Reims Cedex 2, France. E-mail: craig.harris@galderma.com
† Electronic Supplementary Information (ESI) available: Experimental
details for the synthesis and characterization data, copies of 1H and 13C
45 NMR and chiral HPLC spectra. See DOI: 10.1039/b000000x/
1. G. M. Coppola and H. F. Schuster, in Asymmetric Synthesis:
Construction of Chiral Molecules Using Amino Acids. Wiley ed.; New-
York, 1987.
Yielda %
drb
Yieldc % eed %
(7)
Entry
R
(6)
75
72
90/10 (99/1)
87/13 (99/1)
79
67
95
a
2. (a) Jr, J. J. Nestor, Curr. Med. Chem., 2009, 16, 4399; (b) L.-W. Xu
50 and Y. Lu, Org. Biomol. Chem., 2008, 6, 2047.
>99
b
3. (a) M. A. Blaskovich, in Handbook on syntheses of amino acids :
General routes for the syntheses of amino acids First ed.; Oxford
University Press, New York, 2010; (b) A. David, in Process Chemistry in
the Pharmaceutical Industry, CRC Press, 2007, vol. 2, pp 157-179.
55 4. (a) C. Najera and J. M. Sansano, Chem. Rev., 2007, 107, 4584; For
reviews on asymmetric hydrogenation: (b) P. Etayo and A. Vidal-Ferran,
Chem. Soc. Rev., 2013, 42, 728; (c) W. Tang and X. Zhang, Chem. Rev.,
2003, 103, 3029; For reviews on Strecker reaction: (d) J. Wang, X. Liu
and X. Feng, Chem. Rev., 2011, 111, 6947; (e) P. Merino, E. Marqués-
60 López, T. Tejero and R. P. Herrera, Tetrahedron, 2009, 65, 1219; (f) S. J.
Connon, Angew. Chem. Int. Ed., 2008, 47, 1176; For reviews on phase-
transfer catalyzed reaction: (g) S. Shirakawa and K. Maruoka, Angew.
Chem. Int. Ed., 2013, 52, 4312; (h) K. Maruoka, Org. Process Res. Dev.,
2008, 12, 679; (i) M. J. O'Donnell, Acc. Chem. Res., 2004, 37, 506.
65 5. (a) V. A. Soloshonok, H. Ueki and T. K. Ellis, Synlett, 2009, 704; (b)
T. Abellán, R. Chinchilla, N. Galindo, G. Guillena, C. Nájera and J. M.
Sansano, Eur. J. Org. Chem., 2000, 2689; (c) U. Schollkopf, U. Groth and
C. Deng, Angew. Chem. Int. Ed., 1981, 20, 798; (d) R. M. Williams and
M. N. Im, Tetrahedron Lett., 1988, 29, 6075; (e) A. G. Myers, J. L.
70 Gleason, T. Yoon and D. W. Kung, J. Am. Chem. Soc., 1997, 119, 656; (f)
D. Seebach, D. D. Miller, S. Muller and T. Weber, Helv. Chim. Acta,
1985, 68, 949; (g) W. Oppolzer, R. Moretti and C. Zhou, Helv. Chim.
Acta, 1994, 77, 2363.
59
68
90/10 (99/1)
96/4 (99/1)
87
79
96
92
c
d
83
87/13 (99/1)
quant.
96
e
78
46
60
90/10
quant.
quant.
64
81
95
97
f
89/11 (99/1)
86/14 (99/1)
g
h
a
Yields were determined after isolation of the major isomer by flash
chromatography. dr were determined by 1H NMR analysis of crude
b
5 reaction mixtures (dr of the major isomer isolated by flash chromato-
c
graphy). Yields were determined after ion-exchange chromatography.
d ee were determined by chiral HPLC on Chirobiotic T column.
desired amino acid 7h in 64% yield. The enantiomeric purities
were determined by chiral HPLC, confirming that little to no
10 racemization occurred during the cleavage step. While hydrolysis
of the pure (S,S)-diastereoisomers afforded the amino acids in
92-99% enantiomeric purity (7a-e, 7g-h), cleavage of the
diastereoisomeric mixture of 6f gave the free amino acid 7f in
81% ee. The BPB ligand was also recovered in quantitative yield
15 by simple extraction with dichloromethane.
In conclusion, we have developed a novel methodology for the
synthesis of -AAs, using readily available alcohol substrates and
an inexpensive glycine chiral auxiliary. Thanks to the variety,
ready availability and stability of the alcohol electrophilic
20 partners and the facile reaction set-up, this new method allows
access to a wide range of novel optically active -AAs in a
simple library-style operating manner. Furthermore, neither
cryogenic temperatures nor expensive chiral ligands were
necessary to achieve consistently high ee. The methodology
25 reported herein therefore, provides a powerful addition to the
armoury of existing methods to effect the synthesis of novel
chiral non-proteinogenic -AAs.
6. (a) K. C. K. Swamy, N. N. B. Kumar, E. Balaraman and K. V. P. P.
75 Kumar, Chem. Rev., 2009, 109 2551; (b) T. Y. S. But and P. H. Toy,
Chem. Asian J., 2007, 2, 1340.
7. A. J. Reynolds and M. Kassiou, Curr. Org. Chem., 2009, 13, 1610.
8. (a) T. Tsunoda, M. Nagaku, C. Nagino, Y. Kawamura, F. Ozaki, H.
Hioki and S. Itô, Tetrahedron Lett., 1995, 36, 2531; For examples of
80 articles on Mitsunobu-Tsunoda reaction: (b) S. Ito and T. Tsunoda, Pure
Appl. Chem., 1999, 71, 1053; (c) Tsunoda, T.; Nagino, C.; Oguri, M.; Itô,
S., Tetrahedron Lett. 1996, 37, 2459.
9. M. J. O'Donnell, J. M. Boniece and S. E. Earp, Tetrahedron Lett.,
1978, 19, 2641.
85 10. (a) Y. N. Belokon, A. G. Bulychev, S. V. Vitt, Y. T. Struchkov, A.
S. Batsanov, T. V. Timofeeva, V. A. Tsyryapkin, M. G. Ryzhov, L. A.
Lysova, V. I. Bakhmutov and V. M. Belikov, J. Am. Chem. Soc., 1985,
107, 4252; (b) Y. N. Belokon, V. I. Bakhmutov, N. I. Chernoglazova, K.
A. Kochetkov, S. V. Vitt, N. S. Garbalinskaya and V. M. Belikov, J.
90 Chem. Soc., Perkin Trans. 1, 1988, 305.
11. (a) K.-Y. Hung, P. W. R. Harris and M. A. Brimble, J. Org. Chem.,
2010, 75, 8728; (b) A. Popkov and B. De Spiegeleer, Dalton Trans.,
2012, 41, 1430; (c) X. Gu, J. M. Ndungu, W. Qiu, J. Ying, M. D.
Carducci, H. Wooden and V. J. Hruby, Tetrahedron, 2004, 60, 8233; (d)
95 A. Debache, S. Collet, P. Bauchat, D. Danion, L. Euzenat, A. Hercouet
and B. Carboni, Tetrahedron: Asymmetry, 2001, 12, 761.
12. (a) Y. N. Belokon, N. B. Bespalova, T. D. Churkina, I. Cisarova, M.
G. Ezernitskaya, S. R. Harutyunyan, R. Hrdina, H. B. Kagan, P.
Kocovsky, K. A. Kochetkov, O. V. Larionov, K. A. Lyssenko, M. North,
100 M. Polasek, A. S. Peregudov, V. V. Prisyazhnyuk and S. Vyskocil, J. Am.
Chem. Soc., 2003, 125, 12860; (b) H. Ueki, T. K. Ellis, C. H. Martin, T.
U. Boettiger, S. B. Bolene and V. A. Soloshonok, J. Org. Chem., 2003,
68, 7104.
The alkylation of NiII complexes derived from other -AAs
(for the synthesis of dialkylated -AAs), is currently under
30 examination. Further investigations into the effect of modifying
the Tsunoda reagent are also in progress in our laboratory.
The authors thank Auckland Uniservices Ltd., whose interests
in this study are protected under US patent application
nº 61/729,810, the 2011-2012 Dumont D’Urville NZ-France
35 Science & Technology Support Programme for their financial